๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bladder Cancer
Clinical trial register · Italy

Bladder Cancer Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 6830 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
6830
Studies in scope
all four open statuses
4109
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 9 Rome 5 Verona 3 Naples 3 Roma 3
Narrow the registerReset
Recruitment status
Phase
Site location
Milan9 Rome5 Verona3 Naples3 Roma3
All 21 locations
Target enrolment
to

Bladder Cancer trials in Italy

18 of 6830 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients
NCT07231809Non Muscle Invasive Bladder Cancer, Bladder Cancer, Carcinoma in Situ of Bladder, Urinary Bladder Neoplasms
AC.TA. S.r.l.
Not applicable
50
Pozzuoli
2026-10-15
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT07419295Bladder Cancer
Merck Sharp & Dohme LLC
Phase 3
590
Rozzano, Verona, Arezzo, Genova, Milan, Roma
2026-04-23
Recruiting
Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA
NCT07413523Bladder Cancer, Urothelial Carcinoma (UC), Oligometastasis
Istituto Clinico Humanitas
Not applicable
44
Rozzano
2026-02-16
Recruiting
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
NCT07222488Bladder Cancer, Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC
Phase 1/2
45
Verona
2025-12-09
Recruiting
Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
NCT07545694Bladder Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
65
Rome
2025-11-12
Not yet open
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
NCT06528483Bladder Cancer, Bladder Urothelial Carcinoma, Bladder Neoplasm, Muscle-Invasive Bladder Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2
63
Milan
2024-12-02
Recruiting
Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
NCT06878027Bladder Cancer
Regina Elena Cancer Institute
Observational
100
Rome
2024-08-06
Not yet open
Pre-operative Immuno-Nutrition in Radical Cystectomy
NCT06355518Bladder Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
260
Milan, Pavia
2024-04
Active, closed
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
NCT06305767Bladder Cancer
Merck Sharp & Dohme LLC
Phase 1/2
230
Rome, Genoa, Milan, Naples
2024-03-28
Recruiting
Investigator Grant (IG) 2022 27746
NCT06341478Bladder Cancer
IRCCS San Raffaele
Not applicable
153
Milan
2024-03-15
Recruiting
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
NCT06992986Bladder Cancer
Regina Elena Cancer Institute
Observational
50
Rome
2024-02-06
Recruiting
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
NCT05878964Lung Cancer, Breast Cancer, Kidney Cancer, Bladder Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
420
Roma
2023-05-22
Active, closed
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guรฉrin (BCG) in Participants With BCG-naรฏve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
NCT05714202Bladder Cancer
Janssen Research & Development, LLC
Phase 3
1,135
Acquaviva delle Fonti, Asti, Avellino, Castelfranco Veneto, Milan, Naples, Ravenna, Rome
2023-03-23
Recruiting
Robotic Radical Cystectomy Outcomes
NCT04900558Bladder Cancer, Muscle-Invasive Bladder Carcinoma, Oncology, Recurrence
University of Florence
Observational
500
Florence
2021-04-29
Active, closed
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
NCT07265414Prostate Cancer, Bladder Cancer
Istituto Clinico Humanitas
Observational
320
Milan
2021-01-01
Recruiting
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
NCT06167356Non Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial Carcinoma, Bladder Cancer
IRCCS San Raffaele
Observational
20,000
Milan
2013-11-27
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-italy/condition/bladder-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,830 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies listing the condition Bladder Cancer.

How many Bladder Cancer trials are recruiting in Italy?

11 of the 18 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 3 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bladder Cancer), 18 studies
PhaseStudiesRecruitingShare
Observational7638.9%
Not applicable4222.2%
Phase 33116.7%
Phase 1/22111.1%
Phase 2105.6%
Phase 2/3115.6%

Most active sponsors

Lead sponsors with the most studies (Bladder Cancer)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC42
Fondazione Policlinico Universitario Agostino Gemelli IRCCS22
IRCCS San Raffaele22
Istituto Clinico Humanitas21
Regina Elena Cancer Institute22
AC.TA. S.r.l.10
Daiichi Sankyo11
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano10
Fondazione IRCCS Policlinico San Matteo di Pavia10
Janssen Research & Development, LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.